Literature DB >> 16110303

Versican splice variants in human trabecular meshwork and ciliary muscle.

Xiujun Zhao1, Paul Russell.   

Abstract

PURPOSE: Versican, chondroitin sulfate glycoprotein 2, is thought to play a role in regulating aqueous humor outflow and intraocular pressure via the human trabecular meshwork (HTM) of the eye. This protein was upregulated in HTM cells when they were treated with TGF-beta. There are four splice variant forms of versican (V0-V3) with different numbers of glycoaminoglycan (GAG) attachment domains. In this study, we investigated the various isoforms of versican from ocular tissues and cultured cells.
METHODS: HTM and human ciliary muscle (HCM) tissues were dissected from three pairs of donors eyes with no histories of eye disease. Cultures of HTM and HCM cells were established from five donor eyes, and HTM cells were treated for 72 h with 1 ng/ml of either with hrTGF-beta1 or hrTGF-beta2. Total RNA was isolated from cells and tissues from each of the samples. Relative quantitation of gene expression of each variant was detected by real-time PCR with SYBR Green dye.
RESULTS: All four variants of versican existed in each sample. In cultured HTM cells, the two variants with the largest number of GAG domains predominate. The V1 form is about 20% greater than the V0 form. There is an upregulation, particularly in the V0 form, when the cells are cultured. In tissue, the V1 form is about five fold greater than the other three. In the ocular ciliary muscle, the V1 form is the most prominent, but with this tissue, the relative amount of the V0 form did not change when cells were cultured. There was an upregulation of all splice variants in HTM cells when they were cultured with either TGF-beta1 or TGF-beta2. The increase in expression in the HTM with TGF-beta treatments were greatest with the V0 and V2 forms.
CONCLUSIONS: This is the first report about the presence of various forms of versican in the anterior segment of the eye and the alterations in the mRNA patterns of these forms when cells are placed in culture. The results indicate the variants with the largest numbers of GAG attachment domains are the most prominent in the HTM and HCM. The increases in these forms that have the most GAG domains would be consistent with the increases in chondroitin sulfate reported in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110303

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  24 in total

Review 1.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

2.  Versican isoform V1 regulates proliferation and migration in high-grade gliomas.

Authors:  Julia Onken; Sylvia Moeckel; Petra Leukel; Verena Leidgens; Fusun Baumann; Ulrich Bogdahn; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  J Neurooncol       Date:  2014-07-27       Impact factor: 4.130

3.  C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.

Authors:  Runhong Han; Shuai Hu; Weisong Qin; Jinsong Shi; Qin Hou; Xia Wang; Xiaodong Xu; Minchao Zhang; Caihong Zeng; Zhihong Liu; Hao Bao
Journal:  JCI Insight       Date:  2019-04-04

4.  Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.

Authors:  Barbara Kloeckener-Gruissem; John Neidhardt; István Magyar; Henri Plauchu; Jean-Christophe Zech; Laurette Morlé; Sheila M Palmer-Smith; Moira J Macdonald; Véronique Nas; Andrew E Fry; Wolfgang Berger
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

5.  Expression of a hyaluronic acid-binding proteoglycan (versican) in the cynomolgus monkey eye.

Authors:  Kensuke Tajiri; Eisuke Isizaki; Atsuko Nakaizumi; Takatoshi Kobayashi; Teruyo Kida; Hidehiro Oku; Kimitoshi Nakamura; Hiroko Kuwabara; Tsunehiko Ikeda
Journal:  Int Ophthalmol       Date:  2016-01-16       Impact factor: 2.031

6.  TGF-β2-mediated ocular hypertension is attenuated in SPARC-null mice.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Allan R Shepard; Iok-Hou Pang; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-06       Impact factor: 4.799

Review 7.  Trabecular meshwork stiffness in glaucoma.

Authors:  Ke Wang; A Thomas Read; Todd Sulchek; C Ross Ethier
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 8.  Extracellular matrix turnover and outflow resistance.

Authors:  Kate E Keller; Mini Aga; John M Bradley; Mary J Kelley; Ted S Acott
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

9.  Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.

Authors:  Rudolf Fuchshofer; Dietrich A Stephan; Paul Russell; Ernst R Tamm
Journal:  Exp Eye Res       Date:  2009-01-18       Impact factor: 3.467

10.  Response of human trabecular meshwork cells to topographic cues on the nanoscale level.

Authors:  Paul Russell; Joshua Z Gasiorowski; Paul F Nealy; Christopher J Murphy
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.